Welcome

Welcome to the Cochrane Dementia and Cognitive Improvement Group, part of Cochrane’s Mental Health and Neuroscience Network.

Our aim is to provide the highest quality evidence about the care and medical treatment of people with dementia, delirium and other cognitive disorders, and about the diagnosis and prevention of these disorders. We do this by producing systematic reviews addressing questions which are important to patients, their families, and healthcare professionals from all disciplines. You can read more about our scope and our work here.

We welcome contact from anyone who would like to help us to identify important questions, produce or publicise our reviews, or just generally comment on our work.

July 2021 News

Interview with Dr Jenny McCleery, author of the Diagnostic test accuracy of telehealth assessment for dementia and mild cognitive impairment review.

Recently Cochrane Dementia and Cognitive Improvement published 'Diagnostic test accuracy of telehealth assessment for dementia and mild cognitive impairment.' We spoke with Dr Jenny McCleery, one of the authors of this Cochrane review, a Consultant Psychiatrist at Oxford Health NHS Foundation Trust, and the Joint Coordinating Editor, of Cochrane Dementia and Cognitive Improvement Group. Find out about the review findings, how it came about, and how the pandemic prompted this review to be updated by reading the full interview.